Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8839685 | Brain Research | 2018 | 28 Pages |
Abstract
Glutamate levels (Pâ¯=â¯0.006) and NR2B receptor expressions (Pâ¯<â¯0.001) were significantly higher in migraine patients compared to the controls. Chronic migraine patients had higher glutamate level (Pâ¯=â¯0.05). Glutamate and NR2B receptor declined after treatment (Pâ¯<â¯0.001). There was a decline in glutamate levels following rTMS (Pâ¯=â¯0.03), sham stimulation (Pâ¯=â¯0.05) and AMT treatment (Pâ¯=â¯0.003). NR2B receptors also declined after rTMS (Pâ¯=â¯0.005) and AMT treatment (Pâ¯=â¯0.01). It can be concluded that migraine is associated with high plasma glutamate and NR2B receptor which decline following AMT or rTMS therapy.
Keywords
Related Topics
Life Sciences
Neuroscience
Neuroscience (General)
Authors
Gyanesh M. Tripathi, Jayantee Kalita, Usha K. Misra,